May 19, 2019

May 17, 2019

Subscribe to Latest Legal News and Analysis

May 16, 2019

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
12
Apr
HIV/AIDS Drug Litigation Moves Forward Stark & Stark
12
Apr
FDA Announces Public Meeting to Solicit Comments on Regulation of Dietary Supplements Keller and Heckman LLP
12
Apr
New York City Will Ban Pre-Employment Marijuana Testing in 2020 Jackson Lewis P.C.
12
Apr
A Practical Guide for Multistate Employers on Managing the Growing Patchwork of Marijuana Laws Bracewell LLP
11
Apr
USDA Pushes Back Against Washington Post Over New Swine Slaughter Inspection System Keller and Heckman LLP
11
Apr
Presentations Available from EFSA Stakeholder Workshop on Nanoscience and Nanotechnology Bergeson & Campbell, P.C.
10
Apr
USDA’s FSIS Publishes Updated Food Date Label Fact Sheet To Curb Food Waste Keller and Heckman LLP
9
Apr
Ninth Circuit Sends Brain-Booster Claim Case Back to District Court Proskauer Rose LLP
9
Apr
FDA Announces Citizen Petition to Grant Fiber Status to IMO Keller and Heckman LLP
9
Apr
FDA issues statement on future of CBD and Cannabis-derived products, recent enforcement actions Godfrey & Kahn S.C.
9
Apr
FDA Releases Warning Letters to CBD and Hemp Oil Companies McDermott Will & Emery
9
Apr
Fashion & Food Industry Update: More Companies Adopting Blockchain Solutions K&L Gates
8
Apr
CBD Update: FDA Issues Statement, Calls Public Hearing, and Announces Warning Letters on Products Containing Cannabis and its Components Robinson & Cole LLP
8
Apr
Cannabis Finance - SAFE in the STATES and Maybe Beyond? Cadwalader, Wickersham & Taft LLP
8
Apr
Bashful Bladders Bring Problems for Employers Foley & Lardner LLP
8
Apr
Congress Keeping its Focus on Drug Costs Mintz
8
Apr
Latest FDA Data Show Foodborne Pathogens in Fresh Herbs, Guacamole, and Processed Avocado; The Source of a New Multistate E. coli O103 Outbreak Remains a Mystery Keller and Heckman LLP
5
Apr
ECHA PEG Reviewing Draft Appendix for Nanoforms Applicable to the Guidance on Registration and Substance Identification Bergeson & Campbell, P.C.
5
Apr
Ohio Workers’ Compensation System Does Its Part to Mitigate the Opioid Epidemic’s Impact on the State’s Workforce (US) Squire Patton Boggs (US) LLP
5
Apr
New Hazardous Waste Pharmaceutical Rule Imposes New Obligations on Health Care Providers Van Ness Feldman LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS